
Sergio Coffa
Examiner (ID: 9433, Phone: (571)270-3022 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1675, 1654 |
| Total Applications | 931 |
| Issued Applications | 452 |
| Pending Applications | 139 |
| Abandoned Applications | 357 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19464134
[patent_doc_number] => 20240317803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => BCL9 PEPTIDES AND VARIANTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/476860
[patent_app_country] => US
[patent_app_date] => 2023-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18476860
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/476860 | BCL9 PEPTIDES AND VARIANTS THEREOF | Sep 27, 2023 | Abandoned |
Array
(
[id] => 19034147
[patent_doc_number] => 20240083962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/474843
[patent_app_country] => US
[patent_app_date] => 2023-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/474843 | AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF | Sep 25, 2023 | Abandoned |
Array
(
[id] => 19081895
[patent_doc_number] => 20240108696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING VACCINE THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/370941
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18370941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/370941 | COMPOSITIONS AND METHODS FOR IMPROVING VACCINE THERAPY | Sep 20, 2023 | Pending |
Array
(
[id] => 18955157
[patent_doc_number] => 20240043484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => REGENERATIVE POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/471220
[patent_app_country] => US
[patent_app_date] => 2023-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18471220
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/471220 | REGENERATIVE POLYPEPTIDES AND USES THEREOF | Sep 19, 2023 | Abandoned |
Array
(
[id] => 18921282
[patent_doc_number] => 20240024286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => MATERIALS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/363448
[patent_app_country] => US
[patent_app_date] => 2023-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18363448
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/363448 | Materials and methods for improving gastrointestinal function | Jul 31, 2023 | Issued |
Array
(
[id] => 19737202
[patent_doc_number] => 12214009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Compositions and methods for improving bruising and rejuvenating skin
[patent_app_type] => utility
[patent_app_number] => 18/212119
[patent_app_country] => US
[patent_app_date] => 2023-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 37
[patent_no_of_words] => 34120
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212119
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212119 | Compositions and methods for improving bruising and rejuvenating skin | Jun 19, 2023 | Issued |
Array
(
[id] => 19667579
[patent_doc_number] => 12180307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Interleukin-13 binding cyclic oligopeptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/334309
[patent_app_country] => US
[patent_app_date] => 2023-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 16020
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334309
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/334309 | Interleukin-13 binding cyclic oligopeptides and methods of use thereof | Jun 12, 2023 | Issued |
| 18/039130 | BIOLOGICALLY ACTIVE MATERIAL CONJUGATE HAVING BIOTIN MOIETY, FATTY ACID MOIETY, OR COMBINATION THEREOF COUPLED THERETO | May 25, 2023 | Pending |
Array
(
[id] => 18709189
[patent_doc_number] => 20230331801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => IL-2R-BETA-GAMMA BINDING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/321472
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321472
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321472 | IL-2R-BETA-GAMMA BINDING COMPOUNDS | May 21, 2023 | Abandoned |
Array
(
[id] => 18893794
[patent_doc_number] => 20240009279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF
[patent_app_type] => utility
[patent_app_number] => 18/316988
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18316988
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/316988 | TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF | May 11, 2023 | Pending |
Array
(
[id] => 19798962
[patent_doc_number] => 20250064887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => IL-4 DERIVED PEPTIDE FRAGMENTS FOR USE IN THE TREATMENT OF DIABETIC NEPHROPATHY
[patent_app_type] => utility
[patent_app_number] => 18/724136
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18724136
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/724136 | IL-4 derived peptide fragments for use in the treatment of diabetic nephropathy | Apr 27, 2023 | Issued |
Array
(
[id] => 19112772
[patent_doc_number] => 20240124522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => MASP INHIBITORY COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/299600
[patent_app_country] => US
[patent_app_date] => 2023-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18299600
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/299600 | MASP inhibitory compounds and uses thereof | Apr 11, 2023 | Issued |
Array
(
[id] => 20127945
[patent_doc_number] => 12370245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => ALK polypeptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/176013
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 79657
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176013
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176013 | ALK polypeptides and methods of use thereof | Feb 27, 2023 | Issued |
Array
(
[id] => 20577200
[patent_doc_number] => 12569435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Ocular compositions and methods thereof
[patent_app_type] => utility
[patent_app_number] => 18/112468
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5014
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/112468 | Ocular compositions and methods thereof | Feb 20, 2023 | Issued |
Array
(
[id] => 19535551
[patent_doc_number] => 12128084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Use of PAYCS in regulation of intestinal flora, metabolites, and brain neurotransmitters
[patent_app_type] => utility
[patent_app_number] => 18/170163
[patent_app_country] => US
[patent_app_date] => 2023-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 37
[patent_no_of_words] => 4291
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18170163
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/170163 | Use of PAYCS in regulation of intestinal flora, metabolites, and brain neurotransmitters | Feb 15, 2023 | Issued |
Array
(
[id] => 18434239
[patent_doc_number] => 20230181533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => FORMULATIONS WITH REDUCED OXIDATION
[patent_app_type] => utility
[patent_app_number] => 18/105752
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/105752 | FORMULATIONS WITH REDUCED OXIDATION | Feb 2, 2023 | Pending |
Array
(
[id] => 20671939
[patent_doc_number] => 12612439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Mutant bacteriorhodopsin-like-channelrhodopsin ion channel
[patent_app_type] => utility
[patent_app_number] => 18/164297
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 5
[patent_no_of_words] => 18821
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164297
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164297 | Mutant bacteriorhodopsin-like-channelrhodopsin ion channel | Feb 2, 2023 | Issued |
Array
(
[id] => 18675090
[patent_doc_number] => 20230312663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => Regenerative Polypeptides and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/163210
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18163210
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/163210 | Regenerative Polypeptides and Uses Thereof | Jan 31, 2023 | Abandoned |
Array
(
[id] => 18404578
[patent_doc_number] => 20230165929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/160513
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160513 | Treatment of respiratory tract diseases and infections with ascorbic acid compositions | Jan 26, 2023 | Issued |
Array
(
[id] => 18405805
[patent_doc_number] => 20230167156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => SOLID STATE FORMS OF VOCLOSPORIN
[patent_app_type] => utility
[patent_app_number] => 18/100032
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100032 | Solid state forms of voclosporin | Jan 22, 2023 | Issued |